Cargando…
Statin Use in Prostate Cancer: An Update
3-Hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors, known as statins, are commonly prescribed for the treatment of hypercholesterolemia and cardiovascular disease. A systematic review was conducted using the keywords “statin and prostate cancer” within the title search engines including PubM...
Autores principales: | Babcook, Melissa A., Joshi, Aditya, Montellano, Jeniece A., Shankar, Eswar, Gupta, Sanjay |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Libertas Academica
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4946583/ https://www.ncbi.nlm.nih.gov/pubmed/27441003 http://dx.doi.org/10.4137/NMI.S38362 |
Ejemplares similares
-
Green Tea Polyphenols Induce p53-Dependent and p53-Independent Apoptosis in Prostate Cancer Cells through Two Distinct Mechanisms
por: Gupta, Karishma, et al.
Publicado: (2012) -
Metabolic Reprogramming and Predominance of Solute Carrier Genes during Acquired Enzalutamide Resistance in Prostate Cancer
por: Verma, Shiv, et al.
Publicado: (2020) -
The stats are in: an update on statin use in COPD
por: Carlson, Alexa A, et al.
Publicado: (2015) -
Betulinic Acid-Mediated Apoptosis in Human Prostate Cancer Cells Involves p53 and Nuclear Factor-Kappa B (NF-κB) Pathways
por: Shankar, Eswar, et al.
Publicado: (2017) -
Statins in Children, an Update
por: Fiorentino, Riccardo, et al.
Publicado: (2023)